SCHEMBL6164044

SCHEMBL6164044

CC(C)C1CC(=O)c2c(C(C)(C)C)nn(CCO)c2C1

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.39
PDE2A O00408 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164302 0.83 HTT (0.57) HTT
SCHEMBL6165102 0.83 HTT (0.41) HTTPDE2APDE4BPDE4APDE4C
SCHEMBL6166859 0.82 HTT (0.39) HTT
SCHEMBL6163627 0.82 HTT (0.40) HTT
SCHEMBL6166110 0.82 HTT (0.34) HTT
SCHEMBL6166017 0.81 HTT (0.39) HTT
SCHEMBL6164449 0.79 HTT (0.38) HTT
SCHEMBL6165245 0.75 HTT (0.68) HTTPDE2APDE4BPDE4APDE4C
SCHEMBL6164100 0.73 HDAC1 (0.45) HTTPDE2APDE4BPDE4APDE4C
SCHEMBL7490727 0.70 L3MBTL1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed